NCT07674992

Brief Summary

This retrospective cohort study aims to evaluate the incidence and clinical predictors of Central Line-Associated Bloodstream Infections (CLABSI) in patients receiving Peripherally Inserted Central Catheters (PICCs) via the Anesthesia Department.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,239

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2023

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2023

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2026

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

June 2, 2026

Completed
28 days until next milestone

First Posted

Study publicly available on registry

June 30, 2026

Completed
Last Updated

June 30, 2026

Status Verified

June 1, 2026

Enrollment Period

3 years

First QC Date

June 2, 2026

Last Update Submit

June 23, 2026

Conditions

CLABSI - Central Line Associated Bloodstream Infection

Keywords

CathetersPeripherally Inserted Central; Catheter-Related InfectionsCLABSIHemoglobin thresholdRisk factors

Outcome Measures

Primary Outcomes (1)

  • rate of CLABSI

    incidence of CLABSI

    From January 2023 to December 2024

Secondary Outcomes (1)

  • Study the risk factors related to CLABSI, including clinical factors, comorbidities, indication for PICC, and laboratory.

    From January 2023 to December 2024

Study Arms (2)

non CLABSI

non CLABSI

CLABSI

Patient with CLABSI

Other: Hemoglobin level

Interventions

Hemoglobin levelOTHER

Hb ≤ 9.6 g/dL

CLABSI

Eligibility Criteria

Age18 Years+
Sexall(Gender-based eligibility)
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Critcally illed patient or patient with cancer who was inserted PICC line

You may qualify if:

  • Patient with PICC line more than 48 hours, performed by Anesthesia Department from January 2023 to December 2024

You may not qualify if:

  • Incomplete data
  • Patient with reported colonization of PICC line
  • Patient with unintended position of PICC line
  • Patient with any other central venous catheter besides PICC line
  • Patient with previously reported as CLABSI

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Siriraj Hospital

Bangkok Noi, Bangkok, 10700, Thailand

Location

MeSH Terms

Conditions

Catheter-Related Infections

Condition Hierarchy (Ancestors)

Infections

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

June 2, 2026

First Posted

June 30, 2026

Study Start

January 1, 2023

Primary Completion

December 31, 2025

Study Completion

April 1, 2026

Last Updated

June 30, 2026

Record last verified: 2026-06

Data Sharing

IPD Sharing
Will not share

Locations

TH(1)